3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
11
Stomach Neoplasms
6
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Gastric Adenocarcinoma
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Gastric Cancer
2
Adenocarcinoma
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Radioactive Iodine-refractory Differentiated Thyroid Cancer
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Malignant Neoplasms of Digestive Organs
1
Liver Neoplasms
1
Gestational Trophoblastic Disease
1
Gastrointestinal Stromal Tumors
1
Fludzoparib" and Anti-angiogenic
1
Colonic Neoplasms
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Advanced Primary Liver Cancer
1
Advanced Biliary Tract Carcinoma
1
Adebrelimab
1
Interventions
pembrolizumab
3
Carboplatin
3
selpercatinib
2
durvalumab
2
Pemetrexed
2
Cisplatin
2
taletrectinib
1
sotorasib
1
repotrectinib
1
pralsetinib
1
ceralasertib
1
Telescopes
1
Radiosurgery
1
Paclitaxel
1
Gemcitabine
1
Gefitinib
1
Erlotinib Hydrochloride
1
Bevacizumab
1
AZD3759
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Respiratory Tract Diseases
×
apatinib
×
1 year
×
Clear all
No trials found.